Skip to main content
. Author manuscript; available in PMC: 2020 Jun 11.
Published in final edited form as: Ann Surg. 2017 Oct;266(4):610–616. doi: 10.1097/SLA.0000000000002409

TABLE 1.

Study population demographics

Variables Total % (n = 45) Response
p
None (n = 13) Partial (n = 18) Complete (n = 14)

Sex 0.518*
 Male 23 (51%) 5 11 7
 Female 19 (42%) 6 7 6
 Missing 3 (7%)
Age 0.8525
 <50 16 (36%) 5 7 4
 >50 26 (58%) 6 11 9
 Missing 3 (7%)
Tumor difference 0.7553
 Well 3 (7%) 2 1 0
 Moderate 26 (58%) 7 10 9
 Poor 5 (11%) 2 2 1
 Dysplasia 1 (2%) 0 1 0
 Missing 10 (22%)
pT stage <0.0001
 T0 13 (29%) 0 0 13
 T1 4 (9%) 0 4 0
 T2 6 (13%) 2 4 0
 T3 16 (36%) 8 8 0
 T4 3 (7%) 1 2 0
 Missing 3 (7%)
pN stage 0.1031
 N0 28 (62%) 5 11 12
 N1 8 (18%) 4 3 1
 N2 6 (13% 2 4 0
 Missing 3 (7%)
pM stage 0.0550
 M0 38 (84%) 8 17 13
 M1 4 (9%) 3 1 0
 Missing 3 (7%)
Alive 34 (76%) 9 13 12 0.3761
Not alive 8 (18%) 2 5 1
Missing 3 (7%)
*

χ2 test.

Fisher–Freeman–Halton test (extension of Fisher exact test for a 3xk table).